NIH Reporter #1S10OD038181-01A1

Award for Upgrade of NMR Console to Bruker Avance NEO 800 MHz at Dana-Farber Cancer Institute

This award supports the Dana-Farber Cancer Institute's efforts to modernize its research infrastructure: - Government Buyer: - Dana-Farber Cancer Institute, Boston, Massachusetts - OEMs and Vendors: - Bruker (Avance NEO 800 MHz NMR console is a Bruker product line) - Products/Services Requested: - Upgrade of existing NMR console to Avance NEO 800 MHz - Quantity: 1 unit - No specific part number provided - Notable Requirements: - Focused on enhancing structural biology and drug discovery research capabilities - No additional unique technical or service requirements specified - Estimated Contract Value: - Approximately $893,657

Description

This project involves upgrading the NMR console at Dana-Farber Cancer Institute to the Avance NEO 800 MHz model to enhance research capabilities in structural biology and drug discovery. The upgrade is intended to improve the institute's biomedical research infrastructure. The solicitation includes one line item for the upgrade of the NMR console. The response deadline for this opportunity is November 4, 2023.

View original listing